In vitro cytodestruction of human leukemic cells using murine monoclonal antibodies and human complement.
暂无分享,去创建一个
[1] J. Falkenburg,et al. Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies. , 1984, Seminars in hematology.
[2] J. Uhr,et al. Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow. , 1983, Blood.
[3] R. A. Miller,et al. Tumor therapy with monoclonal antibodies. , 1983, Federation proceedings.
[4] G. Hale,et al. Advantages of rat monoclonal antibodies. , 1983, Immunology today.
[5] D. Boue,et al. Antibody affinity may influence antigenic modulation of the common acute lymphoblastic leukemia antigen in vitro. , 1982, Journal of immunology.
[6] M. Borowitz,et al. Characterization and distribution of a 24,000-molecular weight antigen defined by a monoclonal antibody (DU-ALL-1) elicited to common acute lymphoblastic leukemia (cALL) cells. , 1982, Leukemia research.
[7] R. Dillman,et al. Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia. , 1982, Blood.
[8] J. Ritz,et al. Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. , 1982, Blood.
[9] K. Foon,et al. Surface markers on leukemia and lymphoma cells: recent advances. , 1982, Blood.
[10] S. Sallan,et al. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. , 1981, Blood.
[11] M. Greaves,et al. P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody , 1981, The Journal of experimental medicine.
[12] T. Lebien,et al. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. , 1981, Journal of immunology.
[13] M. Greaves,et al. A monoclonal antibody identifying a cell surface antigen shared by common acute lymphoblastic leukemias and B lineage cells. , 1980, Blood.
[14] L. Lampson,et al. Two populations of Ia-like molecules on a human B cell line. , 1980, Journal of immunology.
[15] R. Hurwitz,et al. Characterization of a xenoantiserum produced against three molar KCl-solubilized antigens obtained from a non-T, non-B (pre-B) acute lymphoblastic leukemia cell line. , 1979, Journal of immunology.
[16] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[17] S. Marney,et al. C3 shunt activation in human serum chelated with EGTA. , 1972, Journal of immunology.
[18] H. Colten,et al. Cytotoxic action of antiserum and complement: quantification with a colony inhibition method. , 1971, Immunology.